Last month's settlement of the quantitative computed tomography(QCT) patent dispute between Image Analysis and GE Medical Systemstransformed the two competitors into future partners. The firmsreached a verbal agreement to form an alliance, according to
Last month's settlement of the quantitative computed tomography(QCT) patent dispute between Image Analysis and GE Medical Systemstransformed the two competitors into future partners. The firmsreached a verbal agreement to form an alliance, according to BenA. Arnold, Image Analysis president.
Arnold sued GE in October 1990, alleging patent infringementin the design of a phantom used in converting standard CT systemsto measure bone mass. QCT competes with dual-energy x-ray absorptiometry(DEXA) systems in the diagnosis of osteoporosis.
Image Analysis of Irvine, CA, won a preliminary injunctionfrom Santa Ana, CA, Federal District Court in March prohibitingGE from marketing, using or selling its QCT phantom (SCAN 3/27/91).The ruling withstood GE's subsequent challenge.
"With that, it became clear to both sides that we oughtto be friends," Arnold said.
GE agreed to stop selling its own QCT systems in the U.S.,Japan and Europe, offering Image Analysis phantoms and softwareinstead, he said. A GE spokesperson verified that a preliminaryagreement had been reached. GE is withholding further commentuntil terms are finalized.
The settlement will be pivotal for the future of Image Analysis,a $3-million-a-year company. Domestic sales of the firm's $15,000QCT system slumped after GE's product was introduced in 1988,Arnold said.
Image Analysis has sold 700 systems since its formation in1984. It is responsible for the lion's share of the internationalinstalled base, according to Arnold. Siemens may have sold over500 systems, while GE's share is estimated at 300 to 400 systems.
"As of right now, I'm going to be offering my productto GE, and they're postponing their project worldwide. I'm reallyhappy about that," Arnold said.
Improving Adherence to Best Practices for Incidental Abdominal Aortic Aneurysms on CT and MRI
November 5th 2024In recent interviews, Eric Rohren, M.D., and Krishna Nallamshetty, M.D., discuss the potential of abdominal aortic aneurysms (AAAs) to progress into life-threatening consequences and an emerging AI-powered tool that may bolster adherence to best practice recommendations in radiology reporting of incidental AAA findings on CT and MRI.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).